Showing 26–28 of 28 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Bryan L Peacker, Jonathan C Hwang, Rebecca I Hartman
While immunotherapy has been widely adopted for the treatment of melanoma, its application in patients with complex comorbidities remains challenging. This review explores evidence on the efficacy, safety, and special considerations for the use of immunotherapy in patients with a…
Caterina Davoli, Chiara Rossi, Andrea Ciccarone, Francesca Bertoni, Marina Calamelli, et al.
Treatment for multidrug-resistant or rifampicin-resistant (MDR/RR) tuberculosis (TB) was traditionally long and poorly tolerated. In 2022, the World Health Organization recommended the first 6-month regimen (BPaLM), followed in 2025 by a second short-course option (BDLLfxC) with …
Ravindra Kumar Garg
**INTRODUCTION:** Tuberculous meningitis is frequently associated with significant mortality and persistent neurological sequelae. Diagnosis is often delayed due to nonspecific symptoms and the low sensitivity of cerebrospinal fluid (CSF) tests. Standard pulmonary tuberculosis re…